Hester Biosciences

Hester Biosciences Current Liabilities

Current Liabilities of Hester Biosciences (HESTERBIO.NS) as of Nov 19, 2026.

Current Liabilities

-INR

Last updated:

Current Liabilities of Hester Biosciences is 2026 - INR. Current Liabilities of Hester Biosciences was 2025 1.77 B INR. It decreases by % lower compared to the previous year.

The Hester Biosciences Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2011
205.23 M INR
Jan 1, 2016
432.96 M INR
Jan 1, 2017
436.49 M INR
Jan 1, 2022
1.03 B INR
Jan 1, 2023
1.45 B INR
Jan 1, 2024
1.30 B INR
Jan 1, 2025
1.77 B INR
The Hester Biosciences Current Liabilities history
YEARCurrent LiabilitiesYoY
1.77 BINR+36.09%
1.30 BINR-10.16%
1.45 BINR+41.05%
1.03 BINR+135.68%
436.49 MINR+0.81%
432.96 MINR+110.96%
205.23 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hester Biosciences Stock analysis

What does Hester Biosciences do? Hester Biosciences Ltd. generates revenue through its four operational segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The company sells poultry vaccines such as Gumboro I, Inactivated ND IB, and Live H120, alongside animal health products including Goat Pox Vaccine and PPR Vaccine - Nigerian 75/1. Petcare offerings like Cefshot Tazo Injection and Hestacef CV target veterinary clinics and pet owners. The firm serves agricultural businesses, veterinary practitioners, and pet care providers across India, with its products distributed through trade channels and direct sales to livestock farmers and clinics. Animal Healthcare segment focuses on livestock protection with vaccines for goats and cattle, while Poultry Healthcare provides specialized immunizations for commercial poultry farms. Diagnostic laboratory services complement the product portfolio, supporting livestock health management. The company's product range caters to both large-scale farming operations and smaller veterinary practices, ensuring consistent demand across its target markets. Revenue streams are derived from direct sales to farmers and veterinary clinics, as well as trade distribution networks. The firm's portfolio includes thermostable vaccines for poultry, such as Thermostable ND, which appeals to commercial poultry producers seeking reliable disease prevention solutions. Petcare products like Hestaflam Tablet are marketed to pet owners and veterinary hospitals, expanding the company's reach beyond traditional agricultural sectors. Hester Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hester Biosciences stock

On Eulerpool you can find the complete historical development of Current Liabilities Hester Biosciences since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Hester Biosciences historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Hester Biosciences

All Key Metrics — Hester Biosciences